Drugs in Development
The drugs to treat hepatitis C have seen impressive advances, given that the virus was only identified in 1989. There is a lot of research underway to develop new and better HCV treatment options.
There are many drugs in phase 3 clinical studies. It is expected that some of the studies will be completed, submitted to the Food and Drug Administration (FDA) and approved in 2015.
There is currently no vaccine for hepatitis C as there are for hepatitis A and hepatitis B. Hepatitis C vaccines will be difficult to develop due to the virus’ different genotypes and its ability to change, or mutate during infection. Some progress is being made, but an effective HCV vaccine is not expected for some years.
- For the most update-to-date information about drugs in development to treat hepatitis C, visit the HCV Drug Pipeline
- HCV Treatment is very expensive. There are many patient assistance programs that may provide free drugs or help with insurance co-payments. The HCV Advocate publishes a fact sheet on the various Patient Assistance Programs
GET TESTED. GET TREATED. GET CURED.